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In this study, the mechanisms involved in vasorelaxant effect of the flavonoid quercetin was investigated in isolated aortic rings from
streptozotocin (STZ)-diabetic rats. After 4 weeks, addition of quercetin (0.1 AM–1 mM) caused a significant dose-dependent relaxation of
noradrenaline (NA)- and KCl-preconstricted rings in both control and diabetic groups with a significant inter-group difference of Pb0.01.
Furthermore, both nitro-l-arginine-methyl ester (l-NAME, 100 AM) and indomethacin (10 AM) markedly attenuated the vasorelaxant
responses following quercetin application. Meanwhile, endothelium removal significantly attenuated the quercetin-induced vasorelaxation. It
is concluded that the quercetin can relax the preconstricted rings of aorta in subchronic STZ-diabetic rats through nitric oxide- and -
prostaglandin-mediated pathways, which themselves could be considered as endothelium-dependent.
D 2004 Elsevier Inc. All rights reserved.
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Flavonoids have been known to exhibit various benefi-
cial effects such as platelet antiaggregant, free radical
scavenger, reducing levels of low-density lipoproteins in
plasma (Formica and Regelson, 1995) and modulation of
the vascular tone (Ajay et al., 2003). Several epidemio-
logical studies revealed the inverse association between the
flavonoid intake and reduction in the occurrence of
cardiovascular diseases including myocardial infarction
(Hertog et al., 1993a). Among dietary flavonols, quercetin
is by far the most abundant representing approximately 60%
of the total intake (Hertog et al., 1993b). It has also been
shown that quercetin causes endothelium-dependent relax-
ation in the rat aorta (Fitzpatrick et al., 1993; Duarte et al.,1537-1891/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.vph.2004.12.001
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E-mail address: mehjour@yahoo.com (M. Roghani).1993a). In addition, its cardiovascular protective effects has
been well-documented (Duarte et al., 2001).
Since cardiovascular complications are among the major
causes of mortality in diabetic patients (Garcia et al., 1974),
and enhanced vascular reactivity to vasoconstrictor agents
(Abebe et al., 1990) and impairment of the vascular
relaxation (Tesfamariam, 1994) has been observed in
diabetic condition, the aim of the present study was to
evaluate the possible vasorelaxant effect of quercetin at
early stages of diabetes mellitus and to investigate the
underlying mechanisms in STZ-diabetic rats.2. Materials and methods
2.1. Animal experiments
Male albino Wistar rats (Pasteur’s institute, Tehran, Iran)
weighing 235–275 g (8–10 weeks old) were housed in an42 (2005) 31–35
M. Roghani et al. / Vascular Pharmacology 42 (2005) 31–3532air-conditioned colony room on a light/dark cycle (21F2 8C
and 30–40% humidity) and supplied with standard pelleted
diet and tap water ad libitum. Procedures involving animals
and their care were conducted in conformity with the
institutional guidelines of Shahed University (Tehran, Iran)
and in accordance with the NIH guidelines for the care and
use of laboratory animals.
The animals were randomly divided into two exper-
imental groups: control (n=10) and diabetic (n=12).
Diabetes was induced by a single intraperitoneal injection
of streptozotocin (STZ, 60 mg/kg) dissolved in cold 0.9%
saline solution immediately before use. Diabetes was
verified by a serum glucose level higher than 250 mg/dl
using glucose oxidation method (glucose oxidase kit,
Zistchimie, Tehran).
2.2. Experimental procedure
After 4 weeks, the rats were anesthetized with diethyl
ether, decapitated, and through opening the abdomen,
descending thoracic aorta was carefully excised and placed
in cold physiological saline solution (PSS) containing
(mM): NaCl 118, KCl 4.6, MgSO4 1.2, KH2PO4 1.2,
glucose 11.1, NaHCO3 27.2, ethylenediaminetetraacetic
acid (EDTA) 0.03, and CaCl2 1.8. Thereafter, the aorta
was cleaned of excess connective tissue and fat and cut into
rings of approximately 4 mm in length. One ring of each
pair was left intact, and in the other ring, endothelium was
mechanically removed by gently rotating it on a glass rod.
Aortic rings were suspended between two triangular-shaped
wires. One wire was attached to a fixed tissue support in a
50 ml isolated tissue bath containing PSS (pH 7.4)
maintained at 37 8C and continuously aerated with a
mixture of 5% CO2 and 95% O2. The other end of each
wire attached by a cotton thread to a F60 isometric force
transducer (Narco Biosystems, USA) coupled to a signal
amplifier and connected to computer via an A/D interface.
The rings were allowed to equilibrate for 90 min under a
resting tension of 1.5 g before experiments were begun. This
had been shown in preliminary experiments to be the
optimal resting tension for all groups. During equilibration
period, the rings were washed every 30 min. For examining
the endothelial integrity in intact rings, preconstricted rings
with noradrenaline (NA, 1 AM) were exposed to a single
addition of acetylcholine (ACh, 10 AM). Successful removal
of the endothelium in denuded rings was confirmed by loss
of acetylcholine (105 M)-induced relaxation in precon-
stricted rings by NA (106 M). Furthermore, all experiments
for NA were done in the presence of 1 AM timolol, 1 AM
imipramine, and 1 AM prednisolone to eliminate the effects
of h-adrenoceptors, neuronal uptake, and extraneuronal
uptake respectively. Recording and analysis of data were
performed using the software Physiograph I (Behineh
Arman Co., Tehran).
After an initial equilibration, the aortic rings were
allowed to achieve maximal tension by exposure to highK+ solution (80 mM), which was prepared by replacing the
NaCl concentration of PSS with an equimolar concentration
of KCl. Then, the relaxant responses to different concen-
trations of quercetin (0.1 AM–1 mM) were recorded. After
PSS rinsing (3 times within a period of 30 min), the rings
were constricted with NA (1 AM) and again the relaxant
responses to the same concentrations of quercetin were
recorded. The quercetin-evoked vasorelaxation was
expressed as a percentage of relaxation and the IC50 (the
concentration which produced a 50% maximal relaxation)
was determined from the concentration–response curves.
Meanwhile, for some other rings (n=6 in each group),
cumulative concentration–response curves were obtained
for NA.
The involved mechanisms underlying the vasorelaxant
action of quercetin was examined by pretreatment of the
aortic rings with nitro-l-arginine-methyl ester (l-NAME,
100 AM) and indomethacin (10 AM) individually or in
combination (data not to be presented) 30 min before
addition of the vasoconstrictors and the quercetin. In order
to determine the involvement of intracellular Ca2+ mobi-
lization in the vasorelaxant action of the quercetin, a Ca+2-
free PSS prepared by replacing CaCl2 in PSS with an
equimolar concentration of MgCl2 and the addition of
ethylene-glycol-tetraacetic acid (EGTA, 0.5 AM) to chelate
any free Ca2+ in the medium. After a 15 min preincubation
period in this solution with 2–3 serial washings, NA (1 AM)
was added to stimulate the release of intracellular Ca+2 and
the contraction recorded for at least 2 min. A similar
procedure was repeated with Ca+2-free PSS containing
quercetin (0.1 mM).
2.3. Drugs and chemicals
Noradrenaline bitartrate, acetylcholine-HCl, quercetin,
indomethacin, l-NAME, and streptozotocin were purchased
from Sigma Chemical (St. Louis, Mo., USA). Prednisolone,
imipramine, and timolol were obtained from Temad
(Tehran, Iran). All other chemicals were purchased from
Merck (Germany). The flavonoid quercetin was dissolved in
dimethylsulfoxide (DMSO). The final concentration of
DMSO was less than 0.08%, which was shown to be
devoid of any observable effects on muscle tone. Mean-
while, cumulative addition of this vehicle (DMSO) had no
significant effect (at most 1.5–4% relaxation at the highest
concentration of DMSO) on the thoracic aorta. Indometha-
cin was dissolved in 0.5% w/v sodium bicarbonate. Further
dilutions of the drugs were made in PSS. Meanwhile,
streptozotocin was freshly dissolved in 0.9% saline solution.
2.4. Data and statistical analysis
All values were given as meansFS.E.M. and were
analyzed by student’s t-test or one-way analysis of variance
(ANOVA) followed by Tukey post-hoc test with a signifi-




































Fig. 2. Vasorelaxant effect of quercetin against NA-induced contractions in
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After 4 weeks, body weight of diabetic animals
significantly decreased from 241.7F5.4 g to 207.8F5.8 g
(Pb0.05). Regarding serum glucose level, it significantly
increased to 379.8F15.7 mg/dl from the initial level of
104.7F4.7 mg/dl (Pb0.001). With respect to contractile
response of endothelium-intact aortic rings, NA (1 AM)
induced a sustained contraction of the rat aorta with a peak
tension of 758.23F36.7 and 867.17F41.09 mg in control
and diabetic groups respectively. This difference was not
statistically significant (P=0.53). Meanwhile, after obtain-
ing concentration–response curves for aortic rings from
some diabetic animals (n=6), it was found out that there is a
leftward shift in the related curves, indicating the increased
sensitivity of the tissue. This was despite no significant
changes in the maximum contractile response to NA. On the
other hand, removal of endothelium significantly caused an
enhanced contractile response to NA in both control and
diabetic groups (Pb0.01) (data not shown). Addition of the
quercetin to endothelium-intact rings from control and
diabetic rats induced a dose-dependent relaxation of the
precontracted rings with NA (Fig. 1A). In this respect,
quercetin-induced vasorelaxation of rings from diabetic
group was significantly lower only at concentrations higher
than 100 AM as compared to control group (Pb0.01). It was








































Fig. 1. Vasorelaxant effect of quercetin against NA (A) and high K+ (B)-
induced contractions in aortic rings from control (n=8) and streptozotocin-
diabetic (n=9) rats. *Pb0.01
the presence of l-NAME or indomethacin in control (n=10) (A) and
diabetic (n=11) (B) groups.than 70% for both groups. In this respect, the IC50 (in a
logarithmic scale) was 4.42F1.02 for control and
3.81F0.09 for diabetic groups and their difference did
not reach a significant level. Removal of endothelium
significantly attenuated, but not abolished, the quercetin-
induced vasorelaxation in both control and diabetic groups
(Pb0.01) (data not presented).
Addition of high K+ (80 mM)-containing PSS to the
tissue bath induced a maximal tension of 317.2F15.9 and
374.1F21.09 mg in endothelium-intact rings from control
and diabetic groups respectively. This difference was
statistically significant (Pb0.05). The addition of quercetin
produced a dose-dependent relaxation in both control and
diabetic groups (Fig. 1B). The relaxation response for
diabetic group was significantly lower at quercetin concen-
trations higher than 0.5 mM as compared to control group
(Pb0.01). The maximum vasorelaxation was 55.06F6.25
and 37.22F5.87 mg for control and diabetic groups
respectively with a significant difference of Pb0.01.
Removal of endothelium significantly reduced this vaso-
relaxation in both control and diabetic groups (Pb0.01)
(data has not been shown).
To further evaluate the mechanism of the vasorelaxant
response in control and diabetic groups in endothelium-
intact rings, they were pre-incubated for 30 min with l-
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Fig. 3. Effect of quercetin on NA-induced transient contractions in normal
and Ca+2-free PSS in control (n=9) and diabetic (n=8) groups.
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ment of the tissues with l-NAME or indomethacin
markedly attenuated the inhibitory effect of quercetin
against NA (1 AM)-induced contraction in both control
(Fig. 2A) and diabetic groups (Fig. 2B). In another series of
experiments, for evaluation of the role of intracellular
calcium mobilization in vasorelaxant effect of quercetin,
the effect of this flavonoid was studied against contractions
induced by NA in Ca2+-free PSS. In the absence of
extracellular Ca2+, NA produced a transient contraction
with amplitudes of 187.23F16.25 and 218.12F14.09 mg in
control and diabetic groups respectively. This difference was
not statistically significant. Furthermore, pretreatment of the
aortic rings with quercetin did not significantly reduce the
contractions induced by NA for both groups (Fig. 3).4. Discussion
The present work was performed to investigate the
underlying mechanisms involved in quercetin-induced vaso-
relaxation in NA- and KCl-precontracted aortic rings from
subchronic (4-week) STZ-diabetic rats. The results showed
that there are an enhanced responsiveness of aortic rings
from diabetic animals to KCl, an enhanced sensitivity to NA
with no significant change in the maximum contractile
force, a significant attenuation of the contractile force due to
KCl and NA following quercetin application, and a
significant diminution of the latter response following l-
NAME (an inhibitor of NO synthase) and/or indomethacin
(prostaglandin synthesis inhibitor) pretreatment. Further-
more, endothelial removal significantly reduced, but not
completely abolished quercetin-induced vasorelaxation, and
intracellular mobilization of calcium did not play a role in
this response.
The increased vascular responsiveness to contractile
agents in STZ-diabetic rats has been reported in most
previous studies (Abebe et al., 1990; Ozcelikay et al., 1994).
Although the actual responsible mechanisms have not been
completely understood, some possible factors that couldhave been involved in the increased vascular smooth muscle
responsiveness to non-specific (KCl) and receptor-mediated
agonists (NA) in diabetic rats are deficient endothelial
activity (Karasu and Altan, 1993), enhanced phosphoinosi-
tide (PI) metabolism (Chang et al., 1993), enhanced
sensitivity of calcium channels (Abebe et al., 1990), and
increased sensitivity to adrenergic agonists (Macleod and
McNeill, 1982). Furthermore, oxidative stress is increased
due to excessive production of oxygen-free radicals and
decreased antioxidant defense systems (Oberlet, 1988) and
this phenomenon could be responsible for augmented
contractility together with deficient endothelial activity in
diabetic state (Tesfamariam, 1994). Since at early stages of
diabetes, there is an enhanced sensitivity to a-adrenergic
agonists with no significant changes in the maximum
contractile response, and thereafter, there is a marked
accentuated contractile response (Zhu et al., 2001), this
strongly supports our diabetes model in its initial stages with
regard to vascular abnormalities, and for this reason there
has been no significant increase in contractile responsive-
ness to NA, as observed in this study.
In this study, the involved mechanisms in quercetin-
induced vasorelaxation was evaluated in diabetic animals.
Several lines of evidence support the idea that the relaxant
effect of quercetin was dependent on the production of NO
from endothelial cells (Chen and Pace-Asciak, 1996; Ajay
et al., 2003). The vasorelaxation induced by quercetin in this
study was dependent on the presence of a functional
endothelium and was reduced after inhibition of NO
synthase by l-NAME. Thus, it may be unlikely that the
direct activation of guanylyl cyclase or the inhibition of
phosphodiesterases in smooth muscle could be accounted
for the vasorelaxing effect of quercetin. The possibility that
endothelial vasorelaxant factors derived from cyclooxyge-
nase pathway (prostacyclin PGI2 released from endothelial
cells) participated in the relaxant effect of quercetin (Jaffe
et al., 1982) was also evaluated. In this respect, indometha-
cin pretreatment also significantly attenuated the quercetin-
induced vasorelaxation. Furthermore, in the rat aorta, the
a1-adrenoceptor agonists including NA and phenylephrine
induce an initial transient contraction followed by a tonic
contraction. The initial contraction is mediated by intra-
cellular Ca2+ release, whilst the sustained tonic contraction
results from Ca2+ influx via the receptor-operated calcium
channels (Abebe et al., 1990). In the present study, the effect
of quercetin on intracellular Ca2+ release was examined
indirectly by evaluation of its effect on contractions induced
by NA in calcium-free PSS. In this respect, quercetin failed
to significantly attenuate the initial response to NA. This
implies that at flavonoid concentrations used, the vaso-
relaxant actions of this flavonoid may not involve inhibition
of Ca2+ release from the sarcoplasmic reticulum stores,
which is in contradistinction with some previous reports
(Chan et al., 2000).
The endothelial dependence of the vasodilator effect of
quercetin in rat conductance arteries like aorta has pre-
M. Roghani et al. / Vascular Pharmacology 42 (2005) 31–35 35viously been studied. The relaxation induced by quercetin
and other related flavonoids have reported to be endothe-
lium-independent (Duarte et al., 1993b; Fitzpatrick et al.,
1993) or very weakly inhibited by endothelial removal
(Chen and Pace-Asciak, 1996). In the present work, it was
found out that the vasodilator effect of quercetin is
endothelium-dependent, and its endothelium-independent
effect was only observed at concentrations higher than 103
M (Data not presented). For this reason, at concentrations
used in this study (equal or lower than 103 M),
endothelium removal is expected to significantly attenuate
the vasorelaxation response.
To conclude, the flavonoid quercetin could induce a
dose-dependent vasorelaxation at early stages of diabetes
development and this response follows a NO-, and
prostaglandin-dependent process, the integrity of endothe-
lium is essential for this relaxant response, and finally,
intracellular mobilization of calcium may not play a role in
this phenomenon. Further studies are warranted to evaluate
the beneficial vascular effect of quercetin administration in
diabetic animals.Acknowledgements
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